CHEK2 is identified in the CGC from frameshift germline mutations (i.e. not somatic missense mutations) and annotated as a tumour suppressor whereby frameshifts variants lead to increased risk of familial breast cancer. The gene discussed is CHEK2; the disease is neoplasm.